SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as gold reaches new all-time highs, propelled by a weakening dollar, geopolitical tensions, and aggressive central bank buying. The community remains sharply divided, with many viewing it as an essential hedge against fiat currency debasement and a systemic shift, while others caution that the market is overbought and poised for a significant correction, with ongoing debates comparing its long-term store of value against Bitcoin.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics ($RR) is capturing significant attention following its collaboration with Microsoft's AI Co-Innovation Labs to integrate advanced agentic AI into its ADAM robot, highlighting a pivotal development in the robotics sector. The community is actively discussing the potential for a sustained rally and short squeeze, though some express skepticism about the full impact of the partnership on the company's valuation.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire (RDW) is trending following its selection for the U.S. Department of Defense's $151 billion SHIELD IDIQ contract, which positions the company for significant work in homeland defense and advanced space capabilities. While many are bullish on this development and increasing volume, recognizing RDW's role in the growing space sector, some community members note the contract does not guarantee revenue, leading to increased volatility and divided sentiment.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is trending after reporting a strong earnings and revenue beat, driven by robust data center demand and significant traction for its HAMR-based Mozaic storage solutions in the AI sector. The community is actively discussing optimistic guidance, including extended inventory commitments, and speculating on the potential for a sustained memory supercycle, though some anticipate short-term volatility following the initial post-earnings excitement.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is trending following its latest earnings, which presented mixed results and a conservative outlook, prompting widespread community discussion on the stock's surprising resilience in the face of reported misses. Many are debating whether this indicates underlying strength or market anomalies, especially as the company's long-term strategic investments in domestic manufacturing and the broader semiconductor sector's navigation of trade tensions remain key talking points.

Virtuix Holdings Inc. - Ordinary Shares - Class A

Virtuix Holdings (VTIX) is generating significant buzz following its recent debut on Nasdaq, triggering extreme volatility and active speculative trading. The community is intensely debating its potential as an "AI-driven gaming" play, with discussions highlighting both rapid price movements and frequent trading halts, drawing comparisons to other recent high-momentum listings.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune (ALT) is seeing heightened conversation following institutional validation, including a new Overweight rating and substantial price target from Barclays. The community is actively discussing the potential for an imminent buyout or partnership, emphasizing pemvidutide's "best in class" profile for MASH, superior safety, and weight loss benefits as key differentiators in a competitive market. This has fueled widespread anticipation of a significant short squeeze and a re-rating of the stock.

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.

GRI Bio Inc

GRI Bio Inc. is actively trending following its recent 1-for-28 reverse stock split, which has created an exceptionally low float of approximately 500k shares. This development, coupled with recently announced positive Phase 2a clinical data and secured funding, is driving intense community discussion: many anticipate a significant short squeeze comparing it to prior low-float runners, while others express deep skepticism citing the company's history of frequent dilutions and management's perceived lack of trustworthiness.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending with strong community buzz fueled by expectations of a significant new AI data center partnership, potentially with Amazon, ahead of its upcoming earnings. Investors are highly optimistic about its established Microsoft contract and substantial power capacity, positioning it as a key player in the rapidly expanding AI infrastructure market.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending due to its strategic shift in grocery operations, consolidating physical stores to prioritize online delivery and Whole Foods expansion, while AWS secured a substantial Pentagon cloud contract. This news, coupled with reports of notable analyst upgrades and prominent political figures acquiring calls, is sparking community debate between those anticipating a major breakout fueled by AI and robotics, and others expressing frustration over recent stock performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN...

Lipocine Inc. (NASDAQ:LPCN) Short Interest Update

Lipocine Inc. (NASDAQ:LPCN - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 157,602 shares...

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Reports Encouraging Progress Post Second Interim Safety...

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone PR Newswire SALT LAKE CITY, Dec. 16, 2025 Second Drug...

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in...

Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates

Lipocine (LPCN) delivered earnings and revenue surprises of -5.36% and +15.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 PR Newswire SALT LAKE CITY...

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek PR Newswire SALT LAKE CITY, Nov. 4, 2025 SALT LAKE CITY, Nov. 4, 2025 /PRNewswire...

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

LPCN
Lipocine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LPCN News

LPCNLipocine Inc